Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTAL FORMS OF ERTUGLIFLOZIN AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2019/169988
Kind Code:
A1
Abstract:
The present invention relates to the field of pharmaceutical chemistry, and in particular, to the crystal forms of Ertugliflozin and preparation methods therefor. Said crystal form is crystal form I, crystal form II or crystal form III, and the various crystal forms have different X-ray powder diffraction characteristic peaks. Said crystal forms have better properties such as very high solubility in water, high bioavailability, high stability, and non-hygroscopicity, and can be used for preparing a medicament for treating type 2 diabetes. The preparation methods for the various crystal forms of Ertugliflozin are simple, easy to operate, and have mild conditions.

Inventors:
YU HONGQIN (CN)
YAO JIA (CN)
CHEN YONG (CN)
LUO ZHONGHUA (CN)
HUANG FANGFANG (CN)
Application Number:
PCT/CN2019/074921
Publication Date:
September 12, 2019
Filing Date:
February 13, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUNSHINE LAKE PHARMA CO LTD (CN)
International Classes:
A61K31/7048; C07D493/08; A61P3/10; C07H1/06; C07H9/04
Domestic Patent References:
WO2016088081A12016-06-09
WO2014159151A12014-10-02
Foreign References:
CN102149717A2011-08-10
CN105646603A2016-06-08
CN105646604A2016-06-08
Other References:
DAI YONGZHI: "Synthesis Research of SGLT-2 Inhibitors Ertugliflozin", MASTER'S THESES OF HUMAN UNIVERSITY OF CHINESE MEDICINE, 15 July 2013 (2013-07-15)
Download PDF: